GHAM
TEVA icon

Gilman Hill Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Gilman Hill Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,168
Closed -$223K – 195
2016
Q1 		$223K Buy
+4,168
New +$245K 0.1% 150

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Gilman Hill Asset Management's TEVA Position: Q2 2016 in Review

Gilman Hill Asset Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2016, closing a stake of 4,168 shares — an estimated $223K sold.

Gilman Hill Asset Management first reported a position in TEVA in Q1 2016 and held it in 1 quarter. The position peaked at $223K in Q1 2016. 813 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

  • Gilman Hill Asset Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2016 after selling out during the quarter.
  • Gilman Hill Asset Management sold 4,168 Teva Pharmaceutical Industries Limited shares in Q2 2016, an estimated $223K.
  • Gilman Hill Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2016 and held it in 1 quarter.
  • Gilman Hill Asset Management's Teva Pharmaceutical Industries Limited position peaked at $223K in Q1 2016.
  • 813 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2016.

Based on Gilman Hill Asset Management's 13F filing for Q2 2016, filed 22 Jul 2016.